


Searching News Database: Wellstat Therapeutics
HSMN NewsFeed - 21 Oct 2009
Wellstat Therapeutics and sanofi-aventis Enter Agreement on Novel Therapy for Type II Diabetes
Wellstat Therapeutics and sanofi-aventis Enter Agreement on Novel Therapy for Type II Diabetes
HSMN NewsFeed - 10 Sep 2008
Cytomedix Appoints Dr. Peter A. Clausen as Vice President of Business Development
Cytomedix Appoints Dr. Peter A. Clausen as Vice President of Business Development
